Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Mortimer

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assaysF Dehdashti, J E Mortimer, B A Siegel, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assaysF Dehdashti, J E Mortimer, B A Siegel, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Pageof 3